Sustained outcomes in oral immunotherapy for peanut allergy (POISED study): a large, randomised, double-blind, placebo-controlled, phase 2 study

Abstract
No abstract available
Funding Information
  • NIAID (U19AI104209, R01AI125567)
  • National Institute of Allergy and Infectious Diseases (U19AI104209)

This publication has 36 references indexed in Scilit: